Explore strategies for controlling COPD and improving health, with a focus on management and lifestyle changes.

Researchers have identified new lung function and blood test cutoffs to improve timely chronic hypercapnia management in ...

They display ... Second Phase 3 Clinical Trial Again Shows Dupilumab Lessens Disease in COPD Patients With Type 2 Inflammation May 20, 2024 — Chronic obstructive pulmonary disease patients with ...

Background Whether inhaled corticosteroids (ICSs) reduce major adverse cardiovascular events (MACEs) in people with chronic obstructive pulmonary disease (COPD) is debated. Objectives To establish, ...

Additional research addressing the connection between chronic obstructive pulmonary disease (COPD) and metabolic syndrome is ...

Background: Information about the influence of regular physical activity on the course of chronic obstructive pulmonary disease (COPD) is scarce. A study was undertaken to examine the association ...

But his bleak inner reality seems to have been forged in part by chronic pain.

John Frederick Wilson does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations ...

most commonly manifesting as chronic obstructive pulmonary disease (COPD) or chronic bronchitis/emphysema. These conditions often cause intermittent symptom worsening, reduced physical activity ...

Moderate to vigorous exercise for at least 150 minutes a week was linked to a reduced risk of developing 19 chronic illnesses. These included cardiovascular disease, respiratory disease, diabetes, and ...

More information: Screening Patients for Physical Inactivity Helps Identify Patients at Risk for Cardiometabolic and Chronic Diseases, Preventing Chronic Disease (2024). Lucas J. Carr et al ...

University of Iowa researchers are recommending all patients be surveyed about their physical activity levels, after a new study underscores the link between physical activity and chronic disease.